HHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Harte Hanks Inc (HHS) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trending weakly, has no bullish proprietary signal, no recent news catalyst, no supportive options data, and the near-term probability profile is slightly negative. Based on the data provided, the better call is to avoid buying now.
The technical picture is bearish. Price closed at 2.11, below the previous close of 2.25, with the stock also showing post-market weakness. MACD histogram is negative and still contracting, RSI_6 at 43.26 is neutral but not strong enough to indicate momentum recovery, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is also trading below the pivot at 2.298 and near support at 2.124, which suggests weak structure. The stock trend data also implies mild negative drift over the next day, week, and month.
No news in the recent week. No bullish AI Stock Picker signal. No recent SwingMax signal. No recent congress trading data. No notable positive hedge fund or insider accumulation trends were reported.
Recent price weakness, bearish moving averages, negative MACD histogram, and a slightly bearish short-term stock trend estimate all point to weak momentum. Hedge funds are neutral and insiders are neutral, so there is no evidence of strong sponsorship. Post-market change was also sharply negative at -6.22%, adding to near-term downside pressure.
Financial snapshot data was not available due to an error, so the latest quarter and season cannot be assessed from the provided information.
No analyst rating or price target change data was provided, so there is no evidence of a recent Wall Street upgrade or positive target revision. Overall, Wall Street sentiment cannot be confirmed as bullish from the available data, and the absence of supportive analyst momentum is a negative.
